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I. Introduction 
Ecdysones (or moulting hormones) are poly- 
hydroxysteroids which are involved in ecdysis of 
arthropods. Since the identification of two hormone 
forms (cr and /3) many authors have described the 
chemistry and metabolism of these compounds [ 11. 
Biological [2], physicochemical [3-61 and radio- 
immunological [3,7,8] tests have also been developed 
for their titration. 
No direct data have yet been reported regarding 
the precise localization of intracellular sites of produc- 
tion and storage of ecdysones. An immunocytochemi- 
cal study seemed to us particularly appropriate; its 
success depends on obtaining, essentially for ultra- 
structural studies, specific antibodies with high bind- 
ing parameters. We report here the conditions of anti 
ecdysone antibody production and the radioimmuno- 
assay developed with an iodinated derivative as 
tracer. 
2. Materials and methods 
2.1. Unlabelled steroid compounds 
(Y and /3-ecdysones were supplied by Simes (Italy) 
by courtesy of Dr G. Ferrari. Cholestanol, cholesterol 
and stigmasterol were obtained from Koch Light 
Laboratories and ergosterol from Sigma. 
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2.2. Radiolabelled compounds 
[3H] -@ecdysone (3-4 Ci/mmol) was purchased 
from New England Nuclear and carrier free Na 12’ I
(in NaOH) from the Radiochemical Center, Amersham. 
2.3. Chemicals and solvents 
Carboxymethoxyamine (K and K Laboratories), 
isobutylchloroformiate (Sigma), tri-n-butylamine 
(Merck), bovine serum albumin (BSA)t (Behringwerke), 
tyramine (Eastman) were used without further 
purification. Thin layer chromatography (TLC) was 
performed on pre-coated plates of silica ge] pith 
fluorescent indicator (Merck) and developed in 
methanol/chloroform/water system (60 : 30 : 5, 
v/v/v). 
2.4. Immunogen preparation 
/3-Ecdysone was linked to BSA according to 
Erlanger’s method [9] and used as immunogen. 
2.4.1. /3-Ecdysone carboxymethyloxime (fl-ecdysone 
CMO) synthesis 
/3-ecdysone (25 mg) dissolved in 1.5 ml of pyridine 
was mixed with 125 mg carboxymethoxyamine 
(CMA) and incubated for 8 days at room temperature. 
[3H] -fl-ecdysone was added for estimation of recovery. 
Pyridine was eliminated by successive washings with 
benzene and evaporation to dryness, ethyl acetate- 
30% methanol (10 : 1, v/v) solvent system was added 
to the residue. /3-Ecdysone CM0 extracted in the 
organic phase was purified by TLC. The chromato- 
f Abbreviations: TLC, thin layer chromatography; BSA, 
bovine serum albumin; CMO, carboxymethyloxime; CMA, 
carboxymethoxyamine; PBS, phosphate buffered saline. 
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gram showed two new U.V. absorbing and equally 
radioactive spots (Rf: 0.15 and R,: 0.22). After 
elution with 70% ethanol (v/v) these derivatives 
showed U.V. maximum absorption bands at 252 and 
290 nm respectively. The final recovery, estimated 
by the radioactivity in the two spots, was about 50%. 
2.4.2. /$Ecdysone CMO-BSA coupling 
The two ecdysone derivatives were pooled, dried 
and 5 pmol dissolved in 100 ~1 freshly distilled 
dioxane. Tri-n-butylamine (126 I.tmol) and isobutyl- 
chloroformiate (9.5 pmol) were added and the reac- 
tion mixture was left for 30 min at 0°C. Then 6 mg 
of BSA in 360 ~1 of HzO-dioxane solution (3 : 2, 
v/v) were poured into the mixture. After incubation 
at 4°C for 4 h the conjugate was dialyzed against 
phosphate buffered saline (PBS) (0.1 M, pH 7.4) for 
48 h at 4°C. On the basis of radioactivity of [3H] -/3- 
ecdysone the conjugate was estimated to contain 
20 /3-ecdysone residues per albumin molecule. 
using the chloramine T method [lo] . 10 ~1 of /3- 
ecdysone CM0 tyramine solution (10.6 nmol) was 
evaporated to dryness. Successively 4 ~1 of 0.5 M 
PBS (pH 6.5) 2 1.11 of Na rzsI(350 yCi) and 4 1.11 of
chloramine T (3 mg/ml in 0.05 M PBS) were added 
and the mixture stirred for 1 min, after which the 
reaction was stopped by addition of 4 ~1 of sodium 
metabisulfite (15 mg/ml in 0.05 M phosphate buffer). 
After chromatography and autoradiography, labelled 
materials were isolated, extracted by 70% methanol 
(v/v) and stored at -20°C for further immunological 
tests. 
2.6. standard radioimmunoassay procedure 
2.4.3. Immunization procedure 
Adult male white rabbits were immunized with 
2.6 mg of the conjugate emulsified in complete 
Freund’s adjuvant. At two month intervals, booster 
injections were given intradermally and intravenously 
with the same amount of conjugate. Blood samples 
taken after booster injections were tested for anti- 
bodies binding parameters and the best ones were 
used for assays. 
Phosphate buffer (0.1 M PBS, pH 7.4, 0.1% gelatin, 
0.1% sodium azide) was used routinely to dilute the 
reagents in the assay. In polypropylene test tubes, 
standard steroid or buffer (0.1 ml), ‘251-labelled fl- 
ecdysone (0.1 ml) (18 000 dpm) and diluted anti- 
serum (0.1 ml) were successively added. The mixture 
was stirred gently and incubated for 2 h at room 
temperature and then for 15 min at 0°C. One ml of 
dextran charcoal mixture (Norit A 2.5 g, Dextran T 
70 0.25 mg in 100 ml buffer) was added to each tube. 
Twenty minutes later, the tubes were centrifuged at 
2200 g for 15 min at 4°C. The precipitate was counted 
in a gamma spectrometer. 
3. Results and discussion 
2.5. Tracer preparation 3.1. Immunoreactivity of the two ‘251-labelled 
2.5.1. fl-Ecdysone CM0 tyramine synthesis ecdysone derivatives 
fi-Ecdysone CM0 was linked to tyramine by the 
following procedure: to /3-ecdysone CM0 (1.5 pmol) 
dissolved in freshly distilled dioxane (100 ~1) were 
added tri-n-butylamine (42 pmol) and isobutylchloro- 
formiate (64.5 pmol). The mixture was allowed to 
stand for 15 min at 0°C. Tyramine (10 pmol) in 
N/l00 NaOH (20 ~1) was poured in and left for 1 h 
at 0°C. Thin layer chromatography of the reaction 
mixture revealed the presence of two U.V. absorbing 
products (Rf: 0.72 and R,: 0.78) which were eluted 
by 70% ethanol (v/v). 
The two forms of ecdysone CM0 (Rf: 0.15 and 
R,: 0.22) described above gave two fl-ecdysone CM0 
tyramine derivatives (Rf: 0.72 and R,: 0.78) and 
iodinated materials (Rf: 0.80 and R,: 0.84). The 
immunoreactivities of these labelled materials were 
tested with different antisera dilution. The first one 
(Rf: 0.80) presented a binding capacity three times 
higher than the other (Rf: 0.84) (table 1). All the 
investigations were carried out with the most immuno- 
reactive compound. 
2.5.2. Preparation of radioactive [“51] -@ecdysone 
CM0 tyramine 
fl-Ecdysone CM0 tyramine was labelled with r2’I 
3.2. Sensitivity and specificity of radioimmunoassay 
Fig. 1 shows the standard curves obtained using 
tritiated and iodinated tracers. The latter shows that 
70 pg of unlabelled fi-ecdysone reduces the amount 
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Table 1 
Binding capacity of the two [12sI] +ecdysone CM0 tyramine 
to ecdysone antiserum obtained one week after the first 
booster injection 
Bo 
Initial dilution of antiserum (%) 
l/10 l/100 l/l0 000 l/50 000 
1 89 86 62 25 
2 31 29 18 9 
Bo: percentage of bound radioactivity. 
1 : tracer Rf: 0.80. 
2 : tracer Rf: 0.84. 
of label bound by 50%. The minimum detectable 
level calculated following Rodbard’s method [ 111 is 
5 Pg. 
The parallelism of the two curves suggested that 
the affinity for the antibody was neither impaired by 
introduction of a tyramyl group on the /?-ecdysone 
molecule nor by its iodination. Consequently the 
sensitivity of the assay should depend only on the 
specific radioactivity of the tracer. In our conditions 
this sensitivity was improved a hundred times when 
the specific radioactivity rose from 3 Ci/mmol for the 
tritiated tracer to approximately 400 Ci/mmol for the 
iodinated product [ 121. 
Cross reactions were performed with a-ecdysone, 
cholesterol, cholestanol, stigmasterol and ergosterol. 
As was expected, the lack of a hydroxyl group on the 
Cze atom of the steroid molecule does not prevent 
o-ecdysone from competing with f3-ecdysone from 
20% to 100% depending on individual variations of 
animals in immunological responses. On the other 
hand there was no significant inhibition of label 
binding with the other steroids added in concentra- 
tion 1 up to lo5 pg. 
This sensitive and specific tool could be used 
either for a quantitative assay or for immunocyto- 
chemical and physiological studies. 
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Fig.1. Inhibition of labelled p-ecdysone binding to anti ecdysone serum in the presence of increasing amounts of unlabelled 
p-ecdysone. (o-o) [“H]-p-ecdysone, l/100 antiserum dilution. (0-0) [ “‘I] -labelled-gecdysone, l/20 000 antiserum 
dilution. B: bound radioactivity in presence of competitor. Bo: bound radioactivity in absence of competitor. 
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